Abstract
The process analytical technology (PAT) initiative is now 10 years old. This has
resulted in the development of many tools and software packages dedicated to PAT
application on pharmaceutical processes. However, most applications are restricted
to small molecule drugs, mainly for the relatively simple process steps like drying or
tableting where only a limited number of parameters need to be controlled. A big
challenge for PAT still lies in applications for biopharmaceuticals and then especially
in the cultivation process step, where the quality of a biopharmaceutical product is
largely determined. This review gives an overview of the currently available tools
for monitoring and controlling the biopharmaceutical cultivation step and of the
main challenges for the most common cell platforms (i.e. Escherichia coli, yeast, and mammalian cells) used in biopharmaceutical manufacturing. The real challenge is to understand how intracellular mechanisms (from synthesis to excretion) influence the quality of biopharmaceuticals and how these mechanisms can be monitored and controlled to yield the desired end product quality. Modern “omics” tools and advanced process analyzers have opened up the way for PAT applications for the biopharmaceutical cultivation process step.
Original language | English |
---|---|
Pages (from-to) | 212-223 |
Number of pages | 12 |
Journal | Engineering in Life Sciences |
Volume | 13 |
Issue number | 3 |
DOIs | |
Publication status | Published - 2013 |
Keywords
- performance liquid-chromatography
- time pooling decisions
- fed-batch cultures
- recombinant protein-production
- chemically-defined media
- escherichia-coli w3110
- cell culture
- therapeutic proteins
- approval trends
- gene-expression